Atlas Trials

United Therapeutics

83 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch United Therapeutics

RecordFirmDate
Study to Evaluate the Safety and Efficacy of the GGTA1 KO Thymokidney in Patients With ESRD (NCT07224763)United Therapeutics2026-06-01
Study to Evaluate the Safety and Efficacy of the 10 GE Xenokidney in Patients With ESRD (NCT06878560)United Therapeutics2025-10-29
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD) (NCT06388421)United Therapeutics2025-01-23
Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Progressive Pulmonary Fibrosis (TETON-PPF) (NCT05943535)United Therapeutics2023-10-30
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection (NCT05776225)United Therapeutics2023-08-11
Evaluate Real-World Use of Next Generation Infusion Pumps to Administer Remodulin (NCT05060315)United Therapeutics2023-07-05
A Study of a Mean Pulmonary Artery Pressure-Targeted Approach With Early and Rapid Treprostinil Therapy to Reverse Right Ventricular Remodeling in Participants With Pulmonary Arterial Hypertension (NCT05203510)United Therapeutics2022-10-20
Multinational Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (NCT05255991)United Therapeutics2022-10-04
Extension Study of Inhaled Treprostinil in Subjects With Fibrotic Lung Disease (NCT04905693)United Therapeutics2022-09-06
Study of Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (NCT04708782)United Therapeutics2021-06-01
Study of Ralinepag on Exercise Capacity by Cardiopulmonary Exercise Testing (CPET) in WHO Group 1 PH Subjects (NCT04084678)United Therapeutics2021-01-20
A Safety Study of IV Stem Cell-derived Extracellular Vesicles (UNEX-42) in Preterm Neonates at High Risk for BPD (NCT03857841)United Therapeutics2019-10-09
A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension (NCT03683186)United Therapeutics2019-09-23
EXPEDITE: A Study of Remodulin Induction Followed by Orenitram Optimization to Treat Pulmonary Arterial Hypertension (NCT03497689)United Therapeutics2019-01-31
A Study Evaluating the Efficacy and Safety of Ralinepag to Improve Treatment Outcomes in PAH Patients (NCT03626688)United Therapeutics2019-01-24
Inhaled Treprostinil in Participants With Pulmonary Hypertension Due to Chronic Obstructive Pulmonary Disease (PH-COPD) (NCT03794583)United Therapeutics2018-12-21
A Phase 3 Adaptive Study to Evaluate the Safety and Efficacy of Inhaled Treprostinil in Participants With Pulmonary Hypertension (PH) Due to Chronic Obstructive Pulmonary Disease (COPD) (NCT03496623)United Therapeutics2018-05-08
Open-label Extension of Oral Treprostinil in Subjects With PH Associated With HFpEF (NCT03043651)United Therapeutics2018-01-30
Study to Compare Triple Therapy (Oral Treprostinil, Ambrisentan, and Tadalafil) With Dual Therapy (Ambrisentan, Tadalafil, and Placebo) in Subjects With Pulmonary Arterial Hypertension (NCT02999906)United Therapeutics2017-10-01

Track United Therapeutics automatically

Every clearance here is in the API, with alerts when new ones post.